| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 07/06/2006 | WO2006071988A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 07/06/2006 | WO2006070387A1 PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENO[2,3b]THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI |
| 07/06/2006 | WO2006041985A3 Thienopyridinone compounds and methods of treatment |
| 07/06/2006 | US20060149083 3,4-Ethylenedioxythiophene obtained by heating using a copper catalyst with very high selectivity in the absence of a solvent by heterogeneous reaction ofthe solid alone; high vapor pressure of product enables discharging in gaseous form together with an inert gas stream; minimun use of auxillaries |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/06/2006 | DE102004060412A1 New isopropanol and water mixed solvate of olanzapine used to prepare any other solvate and/or hydrate forms of olanzapine, or anhydrous forms of olanzapine |
| 07/06/2006 | CA2594676A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1675861A1 Pyrimidothiophene compounds |
| 07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/05/2006 | EP1551847B1 3,4-alkylenedioxythiophene compounds and polymers thereof |
| 07/05/2006 | CN1798749A Heteroryl-fused pyrimidinyl compounds as anticancer agents |
| 07/05/2006 | CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071215 Anthelmintic and insecticidal compositions |
| 07/04/2006 | US7071190 Substituted thieno(3,2-d)pyrimidines, such as N-(2-Methoxy-ethyl)-2-(6-(3,5-dimethylphenyl))thieno(3,2-d)pyrimidinyl-4-yl)-hydrazine; treating proliferative diseases such as cancer |
| 07/04/2006 | US7071186 Drug abuse; antiserotonine agents; central nervous system disorders; sleep disorders |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006068991A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006068618A1 New compounds |
| 06/29/2006 | WO2006068591A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
| 06/29/2006 | WO2006068333A1 Method for separating of optically pure thiophene compounds using simulated moving bed chromatography |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | US20060142595 Starting by reacting a 2-halothiophene with a Grignard reagent in a solvent in situ with sulfur, triethylamine hydrochloride, crotonic acid and a base; product is chlorinated, cyclized, chlorosulfonated and aminated, reduced, oxidized, amidated, hydrogenated, neutralized, recrystallized and resolved |
| 06/29/2006 | US20060142590 Asymmetric BIS (indolestyryl) compound and high density recording media utilizing the same |
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142317 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | CA2588220A1 Heteroaromatic derivatives useful as anticancer agents |
| 06/28/2006 | EP1674468A1 Polymorphs of clopidogrel hydrobromide |
| 06/28/2006 | EP1673374A2 Substituted tricyclic heterocycles and their uses |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | CN1795178A Process for synthesizing heterocyclic compounds |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1261437C Glycine-substituted thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067527 Thienopyridine derivatives, their production and use |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067267 Method of assaying pyrrole-containing biological compounds |
| 06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
| 06/22/2006 | WO2006066080A1 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF |
| 06/22/2006 | WO2006064355A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 06/22/2006 | WO2006063732A1 Thieno-pyridine derivatives as gaba-b allosteric enhancers |
| 06/22/2006 | WO2006063709A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease |
| 06/22/2006 | WO2006063615A1 NOVEL SUBSTITUTED THIOPHENEPYRIMIDINONE DERIVATIVES AS INHIBITORS OF 17β-HYDROXYSTEROID DEHYDROGENASE |
| 06/22/2006 | WO2006036883A3 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135539 Thienopyridazinones and their use in modulation of autoimmune disease |
| 06/22/2006 | US20060135529 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 06/22/2006 | US20060135488 protein tyrosine phosphatase 1B (PTP1B) modulators; type 2 diabetes, obesity; increasing insulin sensitivity; 1-Carboxymethoxy-3,8-dithia-cyclopenta[a]indene-2-carboxylic acid |
| 06/22/2006 | CA2591438A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 06/22/2006 | CA2591211A1 Thieno-pyridine derivatives as gaba-b allosteric enhancers |
| 06/22/2006 | CA2590316A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease |
| 06/22/2006 | CA2590233A1 Novel substituted thiophenepyrimidinone derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase |
| 06/22/2006 | CA2589529A1 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1670804A2 Heterobicyclic compounds as pharmaceutically active agents |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | CN1791598A Benzimidazole-derivatives as factor Xa inhibitors |
| 06/21/2006 | CN1791412A Novel compounds and their use in therapy |
| 06/21/2006 | CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/21/2006 | CN1260220C Tricyclic compounds |
| 06/20/2006 | US7064126 Compounds |
| 06/20/2006 | US7064122 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/15/2006 | WO2006063178A2 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/15/2006 | WO2006061642A1 Compounds |
| 06/15/2006 | WO2006021000A3 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | CA2590585A1 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/14/2006 | EP1669359A1 A process for the preparation of olanzapine and an intermediate therefor |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1017675B1 Highly lipophilic camptothecin derivatives |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060831 Process for the preparation of tetrahydrothieno[3,2-c] pyridine derivatives |
| 06/08/2006 | WO2006060702A1 Substitued 3,4-dihydrothieno [2,3-d] pyrmidines as tissue transglutaminase inhibitors |
| 06/08/2006 | WO2006058724A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | WO2006058723A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | WO2006058600A1 Thienopyrimidines as cooling agents |
| 06/08/2006 | WO2006010620A3 Olanzapine salts and their conversion to olanzapine free base |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |